These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32708380)

  • 21. Nutrient intake and urine composition in calcium oxalate stone-forming dogs: comparison with healthy dogs and impact of dietary modification.
    Stevenson AE; Blackburn JM; Markwell PJ; Robertson WG
    Vet Ther; 2004; 5(3):218-31. PubMed ID: 15578454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR; Glenton PA; Byer KJ
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new model of nephrolithiasis involving tubular dysfunction/injury.
    Kumar S; Sigmon D; Miller T; Carpenter B; Khan S; Malhotra R; Scheid C; Menon M
    J Urol; 1991 Nov; 146(5):1384-9. PubMed ID: 1942307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of anti-CD75 reactive proteins on distal and collecting renal tubular epithelial cells in calcium-oxalate stone-forming kidneys in Egypt.
    Kramer G; Steiner GE; Neumayer C; Prinz-Kashani M; Hohenfellner M; Gomha M; Ghoneim M; Newman M; Marberger M
    BJU Int; 2004 Apr; 93(6):822-6. PubMed ID: 15049997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster.
    Yang H; Male M; Li Y; Wang N; Zhao C; Jin S; Hu J; Chen Z; Ye Z; Xu H
    BMC Nephrol; 2018 Jul; 19(1):167. PubMed ID: 29980178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney models of calcium oxalate stone formation.
    Robertson WG
    Nephron Physiol; 2004; 98(2):p21-30. PubMed ID: 15499211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The features of the pathologic changes in chronic oxalate stone disease after 16 week of experimental phase].
    Zharikova GV; Bryukhanov VM; Neymark AI; Zharikov AY; Bobrov IP; Yakushev NN
    Urologiia; 2018 Dec; (5):13-15. PubMed ID: 30575343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
    Tiselius HG; Hallin A; Lindbäck B
    Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].
    Miyazawa K; Suzuki K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):861-9. PubMed ID: 2477580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development.
    Khan SR
    Urol Res; 1995; 23(2):71-9. PubMed ID: 7676537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
    O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
    Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl. (Solanaceae) against ethylene glycol induced urolithiasis in rats.
    Patel PK; Patel MA; Vyas BA; Shah DR; Gandhi TR
    J Ethnopharmacol; 2012 Oct; 144(1):160-70. PubMed ID: 22981722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
    Atmani F; Khan SR
    Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.